首页|慢性乙型肝炎临床治愈的研究现状与前景

慢性乙型肝炎临床治愈的研究现状与前景

扫码查看
慢性乙型肝炎是一种进展性疾病,每年导致大量患者因肝硬化和肝细胞癌死亡.近年来,随着对乙型肝炎病毒感染机制的深入研究,对于核苷(酸)类似物和长效干扰素不同转化策略的研究以及新药开发的进展,乙型肝炎治愈成为可实现的目标.本文就乙型肝炎临床治愈的概念、历史发展、可能的机制、治疗现状,以及新药研发的最新进展作一述评.探讨在治愈过程中面临的挑战以及未来努力的方向,以供临床参考与借鉴.
Current Status and Prospects of Clinical Cure for Chronic Hepatitis B
Chronic hepatitis B is a progressive disease that leads to a significant number of deaths each year due to cirrhosis and hepatocellular carcinoma.In recent years,with the deepening understanding of the mechanisms of Hepatitis B virus infection,advance-ments in different transformation strategies for nucleos(t)ide analogs and long-acting interferons,and the development of new drugs,a cure for hepatitis B has become an achievable goal.This paper reviewed the concept of clinical cure for hepatitis B,its historical devel-opment,potential mechanisms,the current treatment landscape,and the latest progress in new drug development.The challenges encountered in the process of curing hepatitis B and directions for future efforts were also discussed,providing a reference for clinical research and practice.

Chronic hepatitis BClinical cureTreatment strategiesNucleos(t)ide analogsInterferon

彭语晨、邬小萍

展开 >

南昌大学第一附属医院感染性疾病科(南昌 330006)

慢性乙型肝炎 临床治愈 治疗策略 核苷(酸)类似物 干扰素

2025

西南医科大学学报
泸州医学院

西南医科大学学报

影响因子:0.407
ISSN:2096-3351
年,卷(期):2025.48(1)